E-LIB Suche - Ergebnisse für: Anagnostouli, M.

1

Heterogeneity of Baló's concentric sclerosis: a study of ei..:

Tzanetakos, D. ; Vakrakou, A. G. ; Tzartos, J. S....
BMC Neurology. 20 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

2

P4136Neurogenic stunned myoacardium in multiple sclerosis p..:

Gialafos, E ; Tsougos, E ; Andreadou, E...
European Heart Journal. 40 (2019) Supplement_1 - p. , 2019

Link: https://doi.org/10.1093/..

3

A case of Alemtuzumab-induced neutropenia in multiple scler..:

Vakrakou, A. G. ; Tzanetakos, D. ; Valsami, S....
BMC Neurology. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

4

Treatment of neuromyelitis optica and neuromyelitis optica ..:

Evangelopoulos, M.E. ; Andreadou, E. ; Koutsis, G....
Journal of the Neurological Sciences. 372 (2017) - p. 92-96 , 2017

Link: https://doi.org/10.1016/..

5

Brugada sign in a multiple sclerosis patient: Relation to a..:

Gialafos, E. ; Andreadou, E. ; Kokotis, P....
International Journal of Cardiology. 202 (2016) - p. 652-653 , 2016

Link: https://doi.org/10.1016/..

6

Spastic paretic hemifacial contracture in multiple sclerosi..:

Koutsis, G ; Kokotis, P ; Sarrigiannis, P...
Multiple Sclerosis Journal. 14 (2008) 7 - p. 927-932 , 2008

Link: https://doi.org/10.1177/..

7

Serum uric acid and multiple sclerosis:

Rentzos, M. ; Nikolaou, C. ; Anagnostouli, M....
Clinical Neurology and Neurosurgery. 108 (2006) 6 - p. 527-531 , 2006

Link: https://doi.org/10.1016/..

8

IL-15 is elevated in serum and cerebrospinal fluid of patie..:

Rentzos, M. ; Cambouri, C. ; Rombos, A....
Journal of the Neurological Sciences. 241 (2006) 1-2 - p. 25-29 , 2006

Link: https://doi.org/10.1016/..

9

1-31-03 Biotin in CSF and serum in patients with multiple s..:

Anagnostouli, M. ; Livaniou, E. ; Evangelatos, G....
Journal of the Neurological Sciences. 150 (1997) - p. S47 , 1997

Link: https://doi.org/10.1016/..

10

FC15 biotin levels in human cerebrospinal fluid:

Livaniou, E. ; Anagnostouli, M. ; Papageorgiou, C...
European Journal of Pharmaceutical Sciences. 2 (1994) 1-2 - p. 104 , 1994

Link: https://doi.org/10.1016/..

11

Stress Management and Multiple Sclerosis: A Randomized Cont..:

Artemiadis, A. K. ; Vervainioti, A. A. ; Alexopoulos, E. C....
Archives of Clinical Neuropsychology. 27 (2012) 4 - p. 406-416 , 2012

Link: https://doi.org/10.1093/..

12

Heterogeneity of Baló's concentric sclerosis: a study of ei..:

Tzanetakos, D ; Vakrakou, A. G ; Tzartos, J. S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604966/. , 2020

Link: http://www.ncbi.nlm.nih...

13

Clinical trials of disease-modifying agents in pediatric MS..:

Waubant E ; Banwell B ; Wassmer E...
info:eu-repo/semantics/altIdentifier/pmid/31043474. , 2019

Link: http://hdl.handle.net/11..

14

Heterogeneity of Baló's concentric sclerosis: a study of ei..:

D. Tzanetakos ; A. G. Vakrakou ; J. S. Tzartos...
http://link.springer.com/article/10.1186/s12883-020-01971-2. , 2020

Link: https://doi.org/10.1186/..

15

Multiple Sclerosis: Shall We Target CD33?:

Siokas, Vasileios ; Tsouris, Zisis ; Aloizou, Athina-Maria...
Genes. 11 (2020) 11 - p. 1334 , 2020

Link: https://doi.org/10.3390/..